All News #Library
Biotech
Be Bio Begins BeCoMe-9 Trial, First Participant Dosed with BE-101
30 Jul 2025 //
BUSINESSWIRE
Be Biopharma Unveils BE-102 Data for Hypophosphatasia
17 May 2025 //
BUSINESSWIRE
Be Biopharma to Present at ASGCT 28th Annual Meeting
28 Apr 2025 //
BUSINESSWIRE
Be Biopharma Appoints Susan Abu-Absi as COO
03 Mar 2025 //
BUSINESSWIRE
Be Bio Achieves Major Funding And Clinical Development Goals
15 Jan 2025 //
BUSINESSWIRE
Be Biopharma to Present at 66th ASH Annual Meeting
05 Nov 2024 //
BUSINESSWIRE
Be Biopharma Announces Data For Engineered B Cell Medicine
30 Sep 2024 //
BUSINESSWIRE
Be Biopharma: FDA IND Clearance For BE-101 In Hemophilia B
28 May 2024 //
BUSINESSWIRE
Be Biopharma Expands SAB With Gene Therapy Leader Dr. Cannon
21 May 2024 //
BUSINESSWIRE
Be Bio Announces Data Showing BE-101 Produces Active Levels of Factor IX
10 Dec 2023 //
BUSINESSWIRE
Be Biopharma Presents Data Showing B Cell Medicines Produce Antitumor Biologics
31 Oct 2023 //
BUSINESSWIRE

Market Place
Sourcing Support